Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms

World Journal of Surgery

Volumn 30, Issue 5, 2006, Pages 767-774

  Kebebew, Electron ^a,b   Peng, Miao ^b   Reiff, Emily ^b   Duh, Quan Yang ^b   Clark, Orlo H ^a,b   McMillan, Alex ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; COMPLEMENTARY DNA; CYCLIN B1; CYCLIN DEPENDENT KINASE 6; MESSENGER RNA; PROTEIN RAD9; UBIQUITIN C;

ADULT; AGED; ARTICLE; CANCER RISK; CELL CYCLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADENOCARCINOMA, FOLLICULAR; BIOPSY, FINE-NEEDLE; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 33646543983     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-0308-2     Document Type: Article

References (39)

1. Silver RJ, Parangi S. Management of thyroid incidentalomas. Surg Clin North Am 2004;84(3):907-919.
2. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993;328(8):553-559.
3. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004;101(1):3-27.
4. Greaves TS, Olvera M, Florentine BD, et al. Follicular lesions of thyroid: a 5-year fine-needle aspiration experience. Cancer 2000;90(6):335-341.
5. Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002;26(1):41-44.
6. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993;118(4):282-289.
7. Cersosimo E, et al. "Suspicious" thyroid cytologic findings: outcome in patients without immediate surgical treatment. Mayo Clin Proc 1993;68(4):343-348.
8. Gharib H, Goellner JR, Johnson DA. Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies. Clin Lab Med 1993;13(3):699-709.
9. Hooft L, Hoekstra OS, Boers M, et al. Practice, efficacy, and costs of thyroid nodule evaluation: a retrospective study in a Dutch university hospital. Thyroid 2004;14(4):287-293.
10. Ahmed FE. Molecular techniques for studying gene expression in carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2002;20(2):77-116.
11. Pucci B, Giordano A. Cell cycle and cancer. Clin Ter 1999;150(2):135-141.
12. Ohtani K, Iwanaga R, Nakamura M, et al. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F. Oncogene 1999;18(14):2299-2309.
13. Bell SP, Dutta A. DNA replication in eukaryotic cells. Annu Rev Biochem 2002;71333-374.
14. Going JJ, Keith WN, Neilson L, et al. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett"s mucosa. Gut 2002;50(3):373-377.
15. Alison MR, Hunt T, Forbes SJ. Minichromosome maintenance (MCM) proteins may be pre-cancer markers. Gut 2002;50(3):290-291.
16. Freeman A, Morris LS, Mills AD, et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 1999;5(8):2121-2132.
17. Padmanabhan V, Callas P, Philips G, et al. DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer. J Clin Pathol 2004;57(10):1057-1062.
18. Williams GH, Swinn R, Prevost AT, et al. Diagnosis of oesophageal cancer by detection of minichromosome maintenance 5 protein in gastric aspirates. Br J Cancer 2004;91(4):714-719.
19. Dudderidge TJ. Urinary markers in bladder cancer. BJU Int 2003;92(7):823-824.
20. Burton A. Urine test for bladder cancer. Lancet Oncol 2002;3(9):522.
21. Stoeber K, Swinn R, Prevost AT, et al. Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J Natl Cancer Inst 2002;94(14):1071-1079.
22. Stoeber K, Halsall I, Freeman A, et al. Immunoassay for urothelial cancers that detects DNA replication protein Mcm5 in urine. Lancet 1999;354(9189):1524-1525.
23. Murphy N, Ring M, Heffron CC, et al. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 2005;58(5):525-534.
24. Davidson EJ, Morris LS, Scott IS, et al. Minichromosome maintenance (Mcm) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasia. Br J Cancer 2003;88(2):257-262.
25. Grutzmann R, Pilarsky C, Ammerpohl O, et al. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 2004;6(5):611-622.
26. Brake T, Connor JP, Petereit DG, Lambert PF. Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer. Cancer Res 2003;63(23):8173-8180.
27. Shohet JM, Hicks MJ, Pion SE, et al. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma. Cancer Res 2002;62(4):1123-1128.
28. Vasudevan SA, Nuchtern JG. Gene profiling of high risk neuroblastoma. World J Surg 2005;29(3):317-324.
29. Cromer A, Carles A, Millon R, et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 2004;23(14):2484-2498.
30. Guida T, Salvatore G, Faviana P, et al. Mitogenic effects of the up-regulation of minichromosome maintenance (MCM) proteins in anaplastic thyroid carcinoma. J Clin Endocrinol Metab 2005. In press.
31. Kebebew E, Greenspan FS, Clark OH, et al. Anaplastic thyroid cancer: treatment outcome and prognostic factors. Cancer 2005;In press.
32. Bork P, Hofmann K, Bucher P, et al. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. Faseb J 1997;11(1):68-76.
33. Maniwa Y, Yoshimura M, Bermudez VP, et al. Accumulation of hRad9 protein in the nuclei of nonsmall cell lung carcinoma cells. Cancer 2005;103(1):126-132.
34. Finley DJ, Zhu B, Barden CB, Fahey TJ, 3rd. Discrimination of benign and malignant thyroid nodules by molecular profiling. Ann Surg 2004;240(3):425-436; discussion 436-437.
35. Pauws E, Veenboer GJ, Smit JW, et al. Genes differentially expressed in thyroid carcinoma identified by comparison of SAGE expression profiles. Faseb J 2004;18(3):560-561.
36. Raphael SJ. The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia. Endocr Pathol 2002;13(4):301-311.
37. Winzer R, Schmutzler C, Jakobs TC, et al. Reverse transcriptase- polymerase chain reaction analysis of thyrocyte-relevant genes in fine-needle aspiration biopsies of the human thyroid. Thyroid 1998;8(11):981-987.
38. Takano T, Miyauchi A, Matsuzuka F, et al. Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy. J Clin Endocrinol Metab 1999;84(3):951-955.
39. Wilson DB, Staren ED, Prinz RA. Thyroid reoperations: indications and risks. Am Surg 1998;64(7):674-678; discussion 678-679.